Cover Image

Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [<sup>18</sup>F]FDG PET/CT Study Protocol-10 Years of Single-Institutional Experiences

According to the international societies' recommendations, the 2-deoxy-2-[<sup>18</sup>F]fluoro-D-glucose positron emission tomography/computed tomography ([<sup>18</sup>F]FDG PET/CT) technique should not be used as the method of choice in brain tumour diagnosis. Therefo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Agata Pietrzak (Author), Andrzej Marszałek (Author), Tomasz Piotrowski (Author), Adrianna Medak (Author), Katarzyna Pietrasz (Author), Julia Wojtowicz (Author), Hubert Szweda (Author), Krzysztof Matuszewski (Author), Witold Cholewiński (Author)
Format:	Book
Published:	MDPI AG, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Influence of Semiquantitative [<sup>18</sup>F]FDG PET and Hematological Parameters on Survival in HNSCC Patients Using Neural Network Analysis
by: Paulina Cegla, et al.
Published: (2022)

[<sup>68</sup>Ga]FAPI PET for Imaging and Treatment Monitoring in a Preclinical Model of Pulmonary Fibrosis: Comparison to [<sup>18</sup>F]FDG PET and CT
by: Hao Ji, et al.
Published: (2024)

Can the Efficacy of [<sup>18</sup>F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
by: Hazel O'Neill, et al.
Published: (2019)

The place of <sup>18</sup>F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report
by: N. Belfeki, et al.
Published: (2021)

[<sup>68</sup>Ga]Ga-FAP-2286-Synthesis, Quality Control and Comparison with [<sup>18</sup>F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma
by: Anton Amadeus Hörmann, et al.
Published: (2024)

Role of 2-[<sup>18</sup>F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review
by: Salvatore Annunziata, et al.
Published: (2020)

Head-to-Head Comparison between [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi and [<sup>18</sup>F]F-FDG PET/CT Imaging in Patients with Breast Cancer
by: Sanjana Ballal, et al.
Published: (2023)

3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an <sup>18</sup>F-FDG PET/CT Case Report
by: Maria Pepe, et al.
Published: (2024)

<sup>18</sup>FDG PET-CT imaging detects arterial inflammation and early atherosclerosis in HIV-infected adults with cardiovascular disease risk factors
by: Yarasheski Kevin E, et al.
Published: (2012)

[<sup>18</sup>F]FDG PET/CT Imaging Is Associated with Lower In-Hospital Mortality in Patients with Pyogenic Spondylodiscitis-A Registry-Based Analysis of 29,362 Cases
by: Siegmund Lang, et al.
Published: (2024)

DELAYED FDG-PET/CT IMAGES IN PATIENTS WITH BRAIN TUMORS - IMPACT ON VISUAL AND SEMIQUANTITATIVE ASSESSMENT
by: Pavel H. Bochev, et al.
Published: (2013)

Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[<sup>18</sup>F]FDG PET/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis
by: Giorgio Treglia, et al.
Published: (2021)

Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [<sup>11</sup>C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier
by: Louise Breuil, et al.
Published: (2022)

<sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) Functionalized Gold Nanoparticles (GNPs) for Plasmonic Photothermal Ablation of Cancer: A Review
by: Mariano Pontico, et al.
Published: (2023)

If It Works, Don't Touch It? A Cell-Based Approach to Studying 2-[<sup>18</sup>F]FDG Metabolism
by: Eva-Maria Klebermass, et al.
Published: (2021)

[<sup>68</sup>Ga]Ga-DOTA-TOC: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging
by: Ute Hennrich, et al.
Published: (2020)

Osteomyelitis detected by 18F-FDG PET-CT
by: Alberto Martinez-Lorca, et al.
Published: (2024)

[<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
by: Gaëlle Hugon, et al.
Published: (2021)

[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021)

Efficient Production of the PET Radionuclide <sup>133</sup>La for Theranostic Purposes in Targeted Alpha Therapy Using the <sup>134</sup>Ba(p,2n)<sup>133</sup>La Reaction
by: Santiago Andrés Brühlmann, et al.
Published: (2022)

Guidelines for the role of FDG-PET/CT in lung cancer management
by: Hamdan AL-Jahdali, et al.
Published: (2012)

INFLUENCE OF THE FDG-PET/CT ON THE DIAGNOSE AND STAGING OF COLORECTAL CANCER.
by: Nikola Y. Kolev, et al.
Published: (2012)

Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
by: A. V. Parnas, et al.
Published: (2021)

Complex Diagnostic Challenges in Glioblastoma: The Role of <sup>18</sup>F-FDOPA PET Imaging
by: David Sipos, et al.
Published: (2024)

Isotopic Radiolabeling of the Antiretroviral Drug [<sup>18</sup>F]Dolutegravir for Pharmacokinetic PET Imaging
by: Marion Tisseraud, et al.
Published: (2022)

Development of <sup>18</sup>F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging
by: Rocío García-Vázquez, et al.
Published: (2022)

Hidrox<sup>®</sup> Roles in Neuroprotection: Biochemical Links between Traumatic Brain Injury and Alzheimer's Disease
by: Marika Cordaro, et al.
Published: (2021)

<sup>18</sup>F-Radiolabeled Translocator Protein (TSPO) PET Tracers: Recent Development of TSPO Radioligands and Their Application to PET Study
by: Truong Giang Luu, et al.
Published: (2022)

Head-to-Head Comparison of SSTR Antagonist [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>-LM4 with SSTR Agonist [<sup>68</sup>Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study
by: Rahul Viswanathan, et al.
Published: (2024)

Low Molecular Weight Dextran Sulfate (ILB<sup>®</sup>) Administration Restores Brain Energy Metabolism Following Severe Traumatic Brain Injury in the Rat
by: Giacomo Lazzarino, et al.
Published: (2020)

Development of a Promising <sup>18</sup>F-Radiotracer for PET Imaging Legumain Activity In Vivo
by: Chunmei Lu, et al.
Published: (2022)

Optimized <sup>68</sup>Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer
by: Yitian Wu, et al.
Published: (2022)

Synthesis of <sup>68</sup>Ga-Labeled cNGR-Based Glycopeptides and In Vivo Evaluation by PET Imaging
by: Barbara Gyuricza, et al.
Published: (2021)

Binding Parameters of [<sup>11</sup>C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents
by: Avinash H. Bansode, et al.
Published: (2023)

Association of ¹⁸F-FDG PET/CT imaging metabolic parameters with tumour size in breast carcinoma / Ain Nabila Zahari, Mohd Hafizi Mahmud
by: Zahari, Ain Nabila, et al.
Published: (2020)

A study of brainspotting therapy in PTSD using 18FDG brain PET scan to evaluate glucose metabolism changes
by: Mariana Foo, et al.
Published: (2022)

Toward Optimized <sup>89</sup>Zr-Immuno-PET: Side-by-Side Comparison of [<sup>89</sup>Zr]Zr-DFO-, [<sup>89</sup>Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [<sup>89</sup>Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
by: Helen Damerow, et al.
Published: (2022)

Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence
by: Elgin OZKAN, et al.
Published: (2016)

Contribution of [<sup>18</sup>F]FET PET in the Management of Gliomas, from Diagnosis to Follow-Up: A Review
by: Jade Apolline Robert, et al.
Published: (2024)

PET Imaging with [<sup>18</sup>F]ROStrace Detects Oxidative Stress and Predicts Parkinson's Disease Progression in Mice
by: Yi Zhu, et al.
Published: (2024)